Jill Milne Net Worth

Jill Milne biography

Dr. Jill C. Milne Ph.D. serves as President, Chief Executive Officer, Co-Founder, Director of the Company. Dr. Milne worked as head of discovery biology at Sirtris Pharmaceuticals, a biotechnology company, from 2004 to 2008, when it was acquired by GlaxoSmithKline. From 1998 to 2004, Dr. Milne worked at Pfizer Global Research and Development, where she served as the worldwide head of the Drug Pfinder Program and head of the Enzyme Target Group at the Pfizer Discovery Technology Center in Cambridge, Massachusetts. Prior to joining Pfizer, she was an American Cancer Society postdoctoral fellow in the department of biological chemistry and molecular pharmacology at Harvard Medical School from 1995 to 1998. Dr. Milne holds a Ph.D. from Harvard University and a B.A. in biological chemistry from Wellesley College. Milne is qualified to serve on our Board of Directors because of her extensive leadership experience in the life sciences industry and her extensive knowledge of our company based on her role as co-founder and Chief Executive Officer.

What is the salary of Jill Milne?

As the President, Chief Executive Officer, Co-Founder, and Director of Astria Therapeutics Inc, the total compensation of Jill Milne at Astria Therapeutics Inc is $1,032,800. There are no executives at Astria Therapeutics Inc getting paid more.

How old is Jill Milne?

Jill Milne is 52, he's been the President, Chief Executive Officer, Co-Founder, and Director of Astria Therapeutics Inc since 2019. There are 9 older and 1 younger executives at Astria Therapeutics Inc. The oldest executive at Astria Therapeutics Inc is Michael Kishbauch, 71, who is the Independent Director.

What's Jill Milne's mailing address?

Jill's mailing address filed with the SEC is C/O CATABASIS PHARMACEUTICALS, INC.,, 100 HIGH STREET, FLOOR 28, BOSTON, MA, 02110.

Insiders trading at Astria Therapeutics Inc

Over the last 9 years, insiders at Astria Therapeutics Inc have traded over $0 worth of Astria Therapeutics Inc stock and bought 3,064,797 units worth $36,777,564 . The most active insiders traders include Jean George, Nicholas Galakatos, and Lifesciences Ii, L.P.Clarus.... On average, Astria Therapeutics Inc executives and independent directors trade stock every 0 days with the average trade being worth of $2,617,339. The most recent stock trade was executed by Lifesciences Ii, L.P.Clarus... on 30 June 2015, trading 376,695 units of CATB stock currently worth $4,520,340.

What does Astria Therapeutics Inc do?

Astria Therapeutics Inc executives and stock owners

Astria Therapeutics Inc executives and other stock owners filed with the SEC include:

• Jill Milne,
  President, Chief Executive Officer, Co-Founder, Director
• Joanne Donovan,
  Chief Medical Officer
• Andrew Nichols,
  Chief Scientific Officer
• Kenneth Bate,
  Independent Chairman of the Board
• Michael Kishbauch,
  Independent Director
• Gregg Lapointe,
  Independent Director
• Burt Adelman,
  Independent Director
• Hugh Cole,
  Independent Director
• Joanne Beck,
  Independent Director
• Andrew Komjathy,
  Chief Commercial Officer
• Benjamin Harshbarger,
  Senior Vice President, General Counsel
• Noah Clauser,
  Chief Financial Officer
• Andrea Matthews,
  IR Contact Officer
• Rick Modi,
  Chief Business Officer
• Jean George,
  Director
• V, Llcsv Life Sciences Fund...,
  
• Ron Laufer,
  Director
• Michael Jay Ross,
  Director
• Michael Jirousek,
  Chief Scientific Officer
• Lifesciences Ii, L.P.Clarus...,
  
• Ian C. Sanderson,
  Chief Financial Officer
• Ventures, Inc. Med Immune,
  10% owner
• Nicholas Galakatos,
  Director
• Edward K. Hibben,
  Chief Business Officer
• Fred Callori,
  Director
• Jonathan Violin,
  Director
• Deirdre A. Cunnane,
  Chief Legal Officer
• Advisors Llcperceptive Life...,